分子营养 Molecular Nutrition

绿原酸对高脂饲粮诱导非酒精性脂肪肝大鼠细胞凋亡相关基因表达的影响

  • 刘云龙 ,
  • 宋卓 ,
  • 彭冰洁 ,
  • 许诗豪 ,
  • 朱琪 ,
  • 王征
展开
  • 湖南农业大学生物科学技术学院, 长沙 410128

收稿日期: 2015-01-22

  网络出版日期: 2015-07-07

基金资助

国家自然科学基金项目(31071531);湖南省教育厅重点项目(14A071)

Effects of Chlorogenic Acid on Apoptosis-Related Gene Expressions in Rats with Non-Alcoholic Fatty Liver Disease Caused by High-Fat Diet

  • LIU Yunlong ,
  • SONG Zhuo ,
  • PENG Bingjie ,
  • XU Shihao ,
  • ZHU Qi ,
  • WANG Zheng
Expand
  • College of Bioscience & Biotechnology, Hunan Agriculture University, Changsha 410128, China

Received date: 2015-01-22

  Online published: 2015-07-07

摘要

本试验旨在研究绿原酸(CGA)对高脂饲粮所导致的非酒精性脂肪肝(NAFLD)大鼠细胞凋亡相关基因表达的影响。将40只雄性SD大鼠随机分成对照组(NC组)、高脂饲粮模型组(HFD组)、高脂饲粮+低剂量绿原酸组[20 mg/(kg·d),HFD-LC组]和高脂饲粮+高剂量绿原酸组[90 mg/(kg·d),HFD-HC组],每组10只。每天称量体重,12周后处死。取血清检测谷丙转氨酶(ALT)、总胆固醇(TC)、甘油三酯(TG)、游离脂肪酸(FFA)和高密度脂蛋白胆固醇(HDL-c)、低密度脂蛋白胆固醇(LDL-c)含量;取新鲜肝脏组织制备苏木精-伊红(HE)染色切片观察病理变化情况;称量肝脏湿重,计算肝脏指数;采用半定量逆转录PCR(RT-PCR)法测定肝脏组织肿瘤坏死因子-α(TNF-α)、肿瘤坏死因子受体-1(TNFR-1)、半胱氨酸天冬氨酸蛋白酶-8(caspase-8)、半胱氨酸天冬氨酸蛋白酶-3(caspase-3)、B-细胞淋巴瘤/白血病-2原癌基因(Bcl-2)、Bcl-2相关基因(Bax)、核转录因子-κB(NF-κB)、白细胞介素-6(IL-6)的mRNA表达量。结果表明:与NC组对比,HFD组大鼠最终体重(P > 0.05)、肝脏湿重(P < 0.01)、肝脏指数(P < 0.01)、凋亡相关因子mRNA表达量均有上升。与HFD组相比,低剂量绿原酸能够降低最终体重(P > 0.05)、肝脏湿重(P < 0.05)、肝脏指数(P > 0.05),降低凋亡相关因子mRNA表达量;高剂量绿原酸能够降低最终体重(P < 0.05)、肝脏湿重(P < 0.05)、肝脏指数(P > 0.05),降低凋亡相关因子mRNA表达量。切片结果显示HFD组细胞出现大量脂肪空泡,大量细胞出现凋亡形态,绿原酸能够降低脂肪性空泡的数量,改善肝细胞的生理状态,并且高剂量绿原酸作用效果更加明显。由此可见,绿原酸能够缓解高脂饮食所导致的肝细胞凋亡,改善体内的脂肪代谢,对肝脏具有保护作用。

本文引用格式

刘云龙 , 宋卓 , 彭冰洁 , 许诗豪 , 朱琪 , 王征 . 绿原酸对高脂饲粮诱导非酒精性脂肪肝大鼠细胞凋亡相关基因表达的影响[J]. 动物营养学报, 2015 , 27(7) : 2140 -2149 . DOI: 10.3969/j.issn.1006-267x.2015.07.019

Abstract

To investigate the effects of chlorogenic acid (CGA) on the expressions of apoptosis-related genes in rats with nonalcoholic fatty liver disease (NAFLD) caused by high-fat diet. Forty male SD rats were randomly divided into 5 groups: control group (NC group), high-fat diet model group (HFD group), high-fat diet+low dose CGA group [(20 mg/(kg·d), HFD-LC group], and high-fat diet+high dose CGA group [(90 mg/(kg·d), HFD-HC group]. Each group had 10 rats. All rats were weighed everyday and were killed after 12 weeks. Serum contents of alanine transarninase (ALT), total cholesterol (TC), triglyceride (TG), free fatty acid (FFA), high-density lipoprotein cholesterol (HDL-c) and low-density lipoprotein cholesterol (LDL-c) were detected; histological changes of the liver were examined by hematoxylin and eosin staining; liver wet weight and hepatic index were weighed; the mRNA expression levels of tumor necrosis factor-α (TNF-α), tumor necrosis factor receptor-1 (TNFR-1), caspase-8, caspase-3, B cell lymphoma/leukemia-2 (Bcl-2), Bcl-2 related gene (Bax), nuclear factor-κB (NF-κB), and interleukin 6 (IL-6) were assessed by semi-quantification RT-PCR. The results showed as follows: compared with NC group, final body weight (P > 0.05), liver wet weight (P < 0.01), hepatic index (P < 0.01), and the mRNA expression levels of apoptosis-related genes were much higher in HFD group. Compared with HFD group, final body weight (P > 0.05), liver wet weight (P < 0.05), hepatic index (P>0.05), and the mRNA expression levels of apoptosis-related genes were reduced after the treatment of low dose CGA; and high dose of CGA could induce more on those indices [final body weight (P<0.05), liver wet weight (P < 0.05), hepatic index (P>0.05)] than low dose CGA could do. The histological study revealed that there were a lot of fatty vacuoles, a large number of cells with apoptotic morphology. CGA dose dependently reduced the quantity of fatty vacuoles, and improve the physiological state of hepatic cells. It is concluded that CGA can reduce the chance of hepatic apoptosis caused by high-fat diet, improve fat metabolism, and has protection effects on rat liver.

参考文献

[1] LUDWIG J,VIGGIANO T R,MCGILL D B,et al.Nonalcoholic steatohepatitis:Mayo clinic experiences with a hitherto unnamed disease[C]//Mayo Clinic Proceedings.1980,55(7):434-438.

[2] PETTA S,MURATORE C,CRAXÌ A.Non-alcoholic fatty liver disease pathogenesis:the present and the future[J].Digestive and Liver Disease,2009,41(9):615-625.  

[3] GRATTAGLIANO I,DE BARI O,BERNARDO T C,et al.Role of mitochondria in nonalcoholic fatty liver disease-from origin to propagation[J].Clinical Biochemistry,2012,45(9):610-618.  

[4] NARASIMHAN S,GOKULAKRISHNAN K,SAMPATHKUMAR R,et al.Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetes[J].Clinical Biochemistry,2010,43(10/11):815-821.

[5] BECK M A.Selenium and host defence towards viruses[J].Proceedings of the Nutrition Society,1999,58(3):707-711.  

[6] OZAKI M,DESHPANDE S S,ANGKEOW P,et al.Inhibition of the Rac1 GTPase protects against nonlethal ischemia/reperfusion-induced necrosis and apoptosis in vivo[J].The FASEB Journal,2000,14(2):418-429.

[7] MALIKEN B D,NELSON J E,KLINTWORTH H M,et al.Hepatic reticuloendothelial system cell iron deposition is associated with increased apoptosis in nonalcoholic fatty liver disease[J].Hepatology,2013,57(5):1806-1813.  

[8] CHO A S,JEON S M,KIM M J,et al.Chlorogenic acid exhibits anti-obesity property and improves lipid metabolism in high-fat diet-induced-obese mice[J].Food and Chemical Toxicology,2010,48(3):937-943.  

[9] BASSOLI B K,CASSOLLA P,BORBA-MURAD G R,et al.Chlorogenic acid reduces the plasma glucose peak in the oral glucose tolerance test:effects on hepatic glucose release and glycaemia[J].Cell Biochemistry and Function,2008,26(3):320-328.  

[10] 梁秀慈,孟文,钟英丽,等.绿原酸对高脂乳诱导小鼠胰岛素抵抗形成的影响[J].中国药理学通报,2013,29(5):654-658.

[11] LI S Y,CHANG C Q,MA F Y,et al.Modulating effects of chlorogenic acid on lipids and glucose metabolism and expression of hepatic peroxisome proliferator-activated receptor-α in golden hamsters fed on high fat diet[J].Biomedical and Environmental Sciences,2009,22(2):122-129.  

[12] HUANG K,LIANG X C,ZHONG Y L,et al.5-Caffeoylquinic acid decreases diet-induced obesity in rats by modulating PPARα and LXRα transcription[J].Journal of the Science of Food and Agriculture,2015,95(9):1903-1910.  

[13] SATO Y,ITAGAKI S,KUROKAWA T,et al.In vitro and in vivo antioxidant properties of chlorogenic acid and caffeic acid[J].International Journal of Pharmaceutics,2011,403(1/2):136-138.

[14] MUBARAK A,HODGSON J M,CONSIDINE M J,et al.Supplementation of a high-fat diet with chlorogenic acid is associated with insulin resistance and hepatic lipid accumulation in mice[J].Journal of Agricultural and Food Chemistry,2013,61(18):4371-4378.  

[15] BONITA J S,MANDARANO M,SHUTA D,et al.Coffee and cardiovascular disease:in vitro,cellular,animal,and human studies[J].Pharmacological Research,2007,55(3):187-198.  

[16] WANG Z,CLIFFORD M N.Comparison of the profiles of chlorogenic acids and their derivatives from three Chinese traditional herbs by LC-MSn[J].Acta Pharmaceutica Sinica,2008,43(2):185-190.

[17] CLIFFORD M N.Chlorogenic acids and other cinnamates:nature,occurrence and dietary burden[J].Journal of the Science of Food and Agriculture,1999,79(3):362-372.  

[18] 黄继汉,黄晓晖,陈志扬,等.药理试验中动物间和动物与人体间的等效剂量换算[J].中国临床药理学与治疗学,2004,9(9):1069-1072.

[19] KASS G E N.Mitochondrial involvement in drug-induced hepatic injury[J].Chemico-Biological Interactions,2006,163(1/2):145-159.

[20] FELDSTEIN A E,CANBAY A,GUICCIARDI M E,et al.Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice[J].Journal of Hepatology,2003,39(6):978-983.  

[21] 梅玫,陆伟.细胞色素P450 2E1在脂肪性肝病中致病作用研究进展[J].实用肝脏病杂志,2007,10(1):61-64.

[22] LI Z Z,BERK M,MCINTYRE T M,et al.The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity[J].Hepatology,2008,47(5):1495-1503.  

[23] ZHANG W,KUDO H,KAWAI K,et al.Tumor necrosis factor-α accelerates apoptosis of steatotic hepatocytes from a murine model of non-alcoholic fatty liver disease[J].Biochemical and Biophysical Research Communications,2010,391(4):1731-1736.  

[24] HUI J M,HODGE A,FARRELL G C,et al.Beyond insulin resistance in NASH:TNF-α or adiponectin?[J].Hepatology,2004,40(1):46-54.  

[25] DAUGHERITY E K,BALMUS G,AL SAEI A,et al.The DNA damage checkpoint protein ATM promotes hepatocellular apoptosis and fibrosis in a mouse model of non-alcoholic fatty liver disease[J].Cell Cycle,2012,11(10):1918-1928.  

[26] OLTVAL Z N,MILLIMAN C L,KORSMEYER S J.Bcl-2 heterodimerizes in vivo with a conserved homolog,Bax,that accelerates programed cell death[J].Cell,1993,74(4):609-619.  

[27] RIBEIRO P S,CORTEZ-PINTO H,SOLÁ S,et al.Hepatocyte apoptosis,expression of death receptors,and activation of NF-κB in the liver of nonalcoholic and alcoholic steatohepatitis patients[J].The American Journal of Gastroenterology,2004,99(9):1708-1717.  

[28] ELSHARKAWY A M,MANN D A.Nuclear factor-κB and the hepatic inflammation-fibrosis-cancer axis[J].Hepatology,2007,46(2):590-597.  

[29] ARUNKUMAR N,LIU C H,HANG H Y,et al.Toll-like receptor agonists induce apoptosis in mouse B-cell lymphoma cells by altering NF-κB activation[J].Cellular & Molecular Immunology,2013,10(4):360-372.  

[30] QURESHI K,ABRAMS G A.Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease[J].World Journal of Gastroenterology,2007,13(26):3540-3553.  

[31] HONG F,KIM W H,TIAN Z G,et al.Elevated interleukin-6 during ethanol consumption acts as a potential endogenous protective cytokine against ethanol-induced apoptosis in the liver:involvement of induction of Bcl-2 and Bcl-xL proteins[J].Oncogene,2002,21(1):32-43.  

[32] 杨斌,丘岳,王柳萍,等.广西山银花绿原酸体外抗炎作用及分子机制研究[J].中国药理学通报,2009,25(4):542-545.

[33] 胡健萍.代谢综合征小鼠模型的建立及中药复方干预[D].硕士学位论文.北京:北京协和医学院,2009.
文章导航

/